Ilnaz Rahimmanesh

780 total citations
44 papers, 534 citations indexed

About

Ilnaz Rahimmanesh is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Ilnaz Rahimmanesh has authored 44 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 15 papers in Immunology and 10 papers in Oncology. Recurrent topics in Ilnaz Rahimmanesh's work include RNA Interference and Gene Delivery (10 papers), Immunotherapy and Immune Responses (7 papers) and CAR-T cell therapy research (7 papers). Ilnaz Rahimmanesh is often cited by papers focused on RNA Interference and Gene Delivery (10 papers), Immunotherapy and Immune Responses (7 papers) and CAR-T cell therapy research (7 papers). Ilnaz Rahimmanesh collaborates with scholars based in Iran, Italy and China. Ilnaz Rahimmanesh's co-authors include Laleh Shariati, Hossein Khanahmad, Maryam Boshtam, Mina Mirian, Zahra Hejazi, Yasaman Esmaeili, Pooyan Makvandi, Satar Yousefiasl, Shaghayegh Haghjooy Javanmard and Assunta Borzacchiello and has published in prestigious journals such as SHILAP Revista de lepidopterología, Coordination Chemistry Reviews and International Journal of Molecular Sciences.

In The Last Decade

Ilnaz Rahimmanesh

43 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ilnaz Rahimmanesh Iran 14 285 89 73 66 59 44 534
Monika Burg‐Roderfeld Germany 12 303 1.1× 97 1.1× 53 0.7× 78 1.2× 29 0.5× 21 534
Lin Wan China 17 465 1.6× 90 1.0× 144 2.0× 77 1.2× 97 1.6× 38 843
Bodhraj Acharya United States 9 194 0.7× 71 0.8× 156 2.1× 30 0.5× 59 1.0× 11 596
Kelvin S. Ng United States 8 514 1.8× 88 1.0× 212 2.9× 61 0.9× 36 0.6× 8 733
Kun Zhou China 13 459 1.6× 86 1.0× 81 1.1× 66 1.0× 70 1.2× 27 666
Qiyu Tang China 13 246 0.9× 103 1.2× 110 1.5× 123 1.9× 117 2.0× 44 644
Alexandra B. Ysasi United States 13 155 0.5× 54 0.6× 48 0.7× 43 0.7× 67 1.1× 31 642
Adam C. Mirando United States 16 415 1.5× 64 0.7× 70 1.0× 62 0.9× 53 0.9× 23 636
Sami Valkonen Finland 13 496 1.7× 123 1.4× 74 1.0× 53 0.8× 50 0.8× 16 711

Countries citing papers authored by Ilnaz Rahimmanesh

Since Specialization
Citations

This map shows the geographic impact of Ilnaz Rahimmanesh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilnaz Rahimmanesh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilnaz Rahimmanesh more than expected).

Fields of papers citing papers by Ilnaz Rahimmanesh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilnaz Rahimmanesh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilnaz Rahimmanesh. The network helps show where Ilnaz Rahimmanesh may publish in the future.

Co-authorship network of co-authors of Ilnaz Rahimmanesh

This figure shows the co-authorship network connecting the top 25 collaborators of Ilnaz Rahimmanesh. A scholar is included among the top collaborators of Ilnaz Rahimmanesh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilnaz Rahimmanesh. Ilnaz Rahimmanesh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sala, Francesca Della, Ehsan Nazarzadeh Zare‬, Kiavash Hushmandi, et al.. (2025). Stimuli-responsive smart nanomaterials for theranostics of urological cancers. Coordination Chemistry Reviews. 539. 216745–216745. 3 indexed citations
2.
Safarkhani, Moein, Nasim Dana, Yasaman Esmaeili, et al.. (2024). Exploring metal-organic frameworks in gene delivery: From prostate to lung therapeutics. Applied Materials Today. 41. 102449–102449. 8 indexed citations
3.
Rahimmanesh, Ilnaz, et al.. (2024). Evaluation of humoral and cellular immune responses against Vibrio cholerae using oral immunization by multi-epitope-phage-based vaccine. International Immunopharmacology. 134. 112160–112160. 5 indexed citations
4.
Esmaeili, Yasaman, Ilnaz Rahimmanesh, Saeed Karbasi, et al.. (2024). Smart co-delivery of plasmid DNA and doxorubicin using MCM-chitosan-PEG polymerization functionalized with MUC-1 aptamer against breast cancer. Biomedicine & Pharmacotherapy. 173. 116465–116465. 13 indexed citations
5.
Rahimmanesh, Ilnaz, et al.. (2023). Enhanced in vivo anti-tumor efficacy of whole tumor lysate in combination with whole tumor cell-specific polyclonal antibody. Research in Pharmaceutical Sciences. 18(2). 138–148. 2 indexed citations
6.
Abedpoor, Navid, Shaghayegh Haghjooy Javanmard, Anwarul Hasan, et al.. (2023). The molecular perspective on the melanoma and genome engineering of T-cells in targeting therapy. Environmental Research. 237(Pt 2). 116980–116980. 7 indexed citations
7.
Esmaeili, Yasaman, Nasim Dana, Ilnaz Rahimmanesh, et al.. (2023). A comprehensive review on novel targeted therapy methods and nanotechnology-based gene delivery systems in melanoma. European Journal of Pharmaceutical Sciences. 187. 106476–106476. 19 indexed citations
9.
Kouhpayeh, Seyed Amin, et al.. (2023). Phage based vaccine: A novel strategy in prevention and treatment. Heliyon. 9(9). e19925–e19925. 6 indexed citations
10.
Rahimmanesh, Ilnaz, et al.. (2022). Identification of Significant Genes and Pathways Associated with Tenascin-C in Cancer Progression by Bioinformatics Analysis. SHILAP Revista de lepidopterología. 11(1). 17–17. 2 indexed citations
11.
Rahimmanesh, Ilnaz, et al.. (2022). Optimization of Culture Media for Ex vivo T-Cell Expansion for Adoptive T-Cell Therapy. SHILAP Revista de lepidopterología. 11(1). 94–94. 4 indexed citations
12.
Kouhpayeh, Seyed Amin, et al.. (2020). The possible role of glucose-6-phosphate dehydrogenase deficiency in COVID-19 global prevalence and distribution. Journal of Research in Medical Sciences. 25(1). 92–92. 1 indexed citations
13.
Rahimmanesh, Ilnaz, et al.. (2020). The challenging nature of primary T lymphocytes for transfection: Effect of protamine sulfate on the transfection efficiency of chemical transfection reagents. Research in Pharmaceutical Sciences. 15(5). 437–437. 13 indexed citations
14.
Mirian, Mina, et al.. (2019). MicroRNAs as the actors in the atherosclerosis scenario. Journal of Physiology and Biochemistry. 76(1). 1–12. 34 indexed citations
15.
Rahimmanesh, Ilnaz, et al.. (2018). Construction and characterization of human embryonic kidney-(HEK)-293T cell overexpressing truncated α4 integrin. Research in Pharmaceutical Sciences. 13(4). 353–353. 6 indexed citations
16.
Rahimmanesh, Ilnaz, et al.. (2017). Recent Advances in Therapeutic Applications of Induced Pluripotent Stem Cells. Cellular Reprogramming. 19(2). 65–74. 10 indexed citations
17.
Khanahmad, Hossein, et al.. (2017). The silencing effect of miR-30a on ITGA4 gene expression in vitro: an approach for gene therapy. Research in Pharmaceutical Sciences. 12(6). 456–456. 19 indexed citations
18.
Khanahmad, Hossein, Ilnaz Rahimmanesh, Mazdak Ganjalıkhani-Hakemi, et al.. (2016). Expression of biologically active murine interleukin-18 inLactococcus lactis. FEMS Microbiology Letters. 363(21). fnw234–fnw234. 6 indexed citations
19.
Kazemi, Tohid, et al.. (2015). Development of a Stable Cell Line, Overexpressing Human T-cell Immunoglobulin Mucin 1. Iranian Journal of Biotechnology. 13(4). 25–31. 6 indexed citations
20.
Rahimmanesh, Ilnaz, et al.. (2012). High blood pressure and endothelial dysfunction: effects of high blood pressure medication on endothelial dysfunction and new treatments. Journal of Research in Medical Sciences. 17. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026